BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8753809)

  • 21. Inhibition of nitric oxide synthase isoforms by tris-malonyl-C(60)-fullerene adducts.
    Wolff DJ; Papoiu AD; Mialkowski K; Richardson CF; Schuster DI; Wilson SR
    Arch Biochem Biophys; 2000 Jun; 378(2):216-23. PubMed ID: 10860539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
    Symons KT; Massari ME; Nguyen PM; Lee TT; Roppe J; Bonnefous C; Payne JE; Smith ND; Noble SA; Sablad M; Rozenkrants N; Zhang Y; Rao TS; Shiau AK; Hassig CA
    Mol Pharmacol; 2009 Jul; 76(1):153-62. PubMed ID: 19364813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound.
    Flinspach M; Li H; Jamal J; Yang W; Huang H; Silverman RB; Poulos TL
    Biochemistry; 2004 May; 43(18):5181-7. PubMed ID: 15122883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of intermediate, product, and substrate analogs to neuronal nitric oxide synthase: ferriheme is sensitive to ligand-specific effects in the L-arginine binding site.
    Salerno JC; McMillan K; Masters BS
    Biochemistry; 1996 Sep; 35(36):11839-45. PubMed ID: 8794766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
    Cooper GR; Mialkowski K; Wolff DJ
    Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
    Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
    Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase.
    Shankaran K; Donnelly KL; Shah SK; Guthikonda RN; MacCoss M; Humes JL; Pacholok SG; Grant SK; Kelly TM; Wong KK
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4539-44. PubMed ID: 15357988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium.
    Demontis MP; Varoni MV; Volpe AR; Emanueli C; Madeddu P
    Br J Pharmacol; 1998 Jan; 123(1):129-35. PubMed ID: 9484863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
    Babu BR; Griffith OW
    J Biol Chem; 1998 Apr; 273(15):8882-9. PubMed ID: 9535869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor.
    Tsymbalov S; Hagen TJ; Moore WM; Jerome GM; Connor JR; Manning PT; Pitzele BS; Hallinan EA
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3337-9. PubMed ID: 12392746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase.
    Hallinan EA; Tsymbalov S; Finnegan PM; Moore WM; Jerome GM; Currie MG; Pitzele BS
    J Med Chem; 1998 Mar; 41(6):775-7. PubMed ID: 9526553
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of neuronal nitric oxide synthase by phosphatidylinositol 4,5-bisphosphate and phosphatidic acid.
    Hori H; Iwasaki T; Hayashi Y; Kurahashi Y; Matsumura T; Nishino T
    J Biochem; 1999 Nov; 126(5):829-37. PubMed ID: 10544274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and preliminary evaluation of 4-(6-(3-nitroguanidino)hexanamido)pyrrolidine derivatives as potential iNOS inhibitors.
    Liu FZ; Fang H; Zhu HW; Wang Q; Yang Y; Xu WF
    Bioorg Med Chem; 2008 Jan; 16(1):578-85. PubMed ID: 17937988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors.
    Blasko E; Glaser CB; Devlin JJ; Xia W; Feldman RI; Polokoff MA; Phillips GB; Whitlow M; Auld DS; McMillan K; Ghosh S; Stuehr DJ; Parkinson JF
    J Biol Chem; 2002 Jan; 277(1):295-302. PubMed ID: 11689556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of boronic acid analogs of L-arginine as alternate substrates or inhibitors of nitric oxide synthase.
    Lebarbier C; Carreaux F; Carboni B; Boucher JL
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2573-6. PubMed ID: 9873583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine is a strong inhibitor of brain nitric oxide synthase: possible consequences for the origin of its therapeutic effects.
    Renodon A; Boucher JL; Sari MA; Delaforge M; Ouazzani J; Mansuy D
    FEBS Lett; 1997 Apr; 406(1-2):33-6. PubMed ID: 9109381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From natural product-inspired pyrrolidine scaffolds to the development of new human Golgi α-mannosidase II inhibitors.
    Cheng TJ; Chan TH; Tsou EL; Chang SY; Yun WY; Yang PJ; Wu YT; Cheng WC
    Chem Asian J; 2013 Nov; 8(11):2600-4. PubMed ID: 23943613
    [No Abstract]   [Full Text] [Related]  

  • 38. Guanidine-substituted imidazoles as inhibitors of nitric oxide synthase.
    Atkinson RN; King SB
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2953-8. PubMed ID: 10571154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and immunoaffinity purification of human inducible nitric-oxide synthase. Inhibition studies with 2-amino-5,6-dihydro-4H-1,3-thiazine.
    Calaycay JR; Kelly TM; MacNaul KL; McCauley ED; Qi H; Grant SK; Griffin PR; Klatt T; Raju SM; Nussler AK; Shah S; Weidner JR; Williams HR; Wolfe GC; Geller DA; Billiar TR; MacCoss M; Mumford RA; Tocci MJ; Schmidt JA; Wong KK; Hutchinson NI
    J Biol Chem; 1996 Nov; 271(45):28212-9. PubMed ID: 8910438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the divalent effect in fucosidase inhibition with stereoisomeric pyrrolidine dimers.
    Hottin A; Wright DW; Moreno-Clavijo E; Moreno-Vargas AJ; Davies GJ; Behr JB
    Org Biomol Chem; 2016 May; 14(20):4718-27. PubMed ID: 27138139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.